Nctid:
NCT00000120
Payload:
{"hasResults"=>false, "derivedSection"=>{"miscInfoModule"=>{"versionHolder"=>"2024-09-05"}, "conditionBrowseModule"=>{"meshes"=>[{"id"=>"D000002690", "term"=>"Chlamydia Infections"}, {"id"=>"D000009878", "term"=>"Ophthalmia Neonatorum"}], "ancestors"=>[{"id"=>"D000002694", "term"=>"Chlamydiaceae Infections"}, {"id"=>"D000016905", "term"=>"Gram-Negative Bacterial Infections"}, {"id"=>"D000001424", "term"=>"Bacterial Infections"}, {"id"=>"D000001423", "term"=>"Bacterial Infections and Mycoses"}, {"id"=>"D000007239", "term"=>"Infections"}, {"id"=>"D000015231", "term"=>"Sexually Transmitted Diseases, Bacterial"}, {"id"=>"D000012749", "term"=>"Sexually Transmitted Diseases"}, {"id"=>"D000003141", "term"=>"Communicable Diseases"}, {"id"=>"D000091662", "term"=>"Genital Diseases"}, {"id"=>"D000091642", "term"=>"Urogenital Diseases"}, {"id"=>"D000015817", "term"=>"Eye Infections"}, {"id"=>"D000005128", "term"=>"Eye Diseases"}, {"id"=>"D000003234", "term"=>"Conjunctivitis, Bacterial"}, {"id"=>"D000015818", "term"=>"Eye Infections, Bacterial"}, {"id"=>"D000016870", "term"=>"Neisseriaceae Infections"}, {"id"=>"D000003231", "term"=>"Conjunctivitis"}, {"id"=>"D000003229", "term"=>"Conjunctival Diseases"}, {"id"=>"D000007232", "term"=>"Infant, Newborn, Diseases"}], "browseLeaves"=>[{"id"=>"M10283", "name"=>"Infections", "relevance"=>"LOW"}, {"id"=>"M6368", "name"=>"Communicable Diseases", "relevance"=>"LOW"}, {"id"=>"M6455", "name"=>"Conjunctivitis", "relevance"=>"LOW"}, {"id"=>"M5934", "name"=>"Chlamydia Infections", "asFound"=>"Chlamydia Infections", "relevance"=>"HIGH"}, {"id"=>"M12808", "name"=>"Endophthalmitis", "relevance"=>"LOW"}, {"id"=>"M12809", "name"=>"Ophthalmia Neonatorum", "asFound"=>"Ophthalmia Neonatorum", "relevance"=>"HIGH"}, {"id"=>"M4722", "name"=>"Bacterial Infections", "relevance"=>"LOW"}, {"id"=>"M19249", "name"=>"Gram-Negative Bacterial Infections", "relevance"=>"LOW"}, {"id"=>"M12136", "name"=>"Mycoses", "relevance"=>"LOW"}, {"id"=>"M4721", "name"=>"Bacterial Infections and Mycoses", "relevance"=>"LOW"}, {"id"=>"M15558", "name"=>"Sexually Transmitted Diseases", "relevance"=>"LOW"}, {"id"=>"M17935", "name"=>"Sexually Transmitted Diseases, Bacterial", "relevance"=>"LOW"}, {"id"=>"M2876", "name"=>"Genital Diseases", "relevance"=>"LOW"}, {"id"=>"M2875", "name"=>"Urogenital Diseases", "relevance"=>"LOW"}, {"id"=>"M18371", "name"=>"Eye Infections", "relevance"=>"LOW"}, {"id"=>"M8271", "name"=>"Eye Diseases", "relevance"=>"LOW"}, {"id"=>"M6458", "name"=>"Conjunctivitis, Bacterial", "relevance"=>"LOW"}, {"id"=>"M18372", "name"=>"Eye Infections, Bacterial", "relevance"=>"LOW"}, {"id"=>"M19218", "name"=>"Neisseriaceae Infections", "relevance"=>"LOW"}, {"id"=>"M6453", "name"=>"Conjunctival Diseases", "relevance"=>"LOW"}, {"id"=>"M10276", "name"=>"Infant, Newborn, Diseases", "relevance"=>"LOW"}, {"id"=>"T2593", "name"=>"Gonococcal Conjunctivitis", "asFound"=>"Ophthalmia Neonatorum", "relevance"=>"HIGH"}], "browseBranches"=>[{"name"=>"Infections", "abbrev"=>"BC01"}, {"name"=>"All Conditions", "abbrev"=>"All"}, {"name"=>"Symptoms and General Pathology", "abbrev"=>"BC23"}, {"name"=>"Eye Diseases", "abbrev"=>"BC11"}, {"name"=>"Urinary Tract, Sexual Organs, and Pregnancy Conditions", "abbrev"=>"BXS"}, {"name"=>"Diseases and Abnormalities at or Before Birth", "abbrev"=>"BC16"}, {"name"=>"Rare Diseases", "abbrev"=>"Rare"}]}, "interventionBrowseModule"=>{"meshes"=>[{"id"=>"D000004917", "term"=>"Erythromycin"}, {"id"=>"D000004918", "term"=>"Erythromycin Estolate"}, {"id"=>"D000015643", "term"=>"Erythromycin Ethylsuccinate"}, {"id"=>"C000011462", "term"=>"Erythromycin stearate"}, {"id"=>"D000012835", "term"=>"Silver Nitrate"}], "ancestors"=>[{"id"=>"D000000900", "term"=>"Anti-Bacterial Agents"}, {"id"=>"D000000890", "term"=>"Anti-Infective Agents"}, {"id"=>"D000005765", "term"=>"Gastrointestinal Agents"}, {"id"=>"D000011500", "term"=>"Protein Synthesis Inhibitors"}, {"id"=>"D000004791", "term"=>"Enzyme Inhibitors"}, {"id"=>"D000045504", "term"=>"Molecular Mechanisms of Pharmacological Action"}, {"id"=>"D000000891", "term"=>"Anti-Infective Agents, Local"}], "browseLeaves"=>[{"id"=>"M8068", "name"=>"Erythromycin", "asFound"=>"Eosinophilic", "relevance"=>"HIGH"}, {"id"=>"M8069", "name"=>"Erythromycin Estolate", "asFound"=>"Eosinophilic", "relevance"=>"HIGH"}, {"id"=>"M18236", "name"=>"Erythromycin Ethylsuccinate", "asFound"=>"Eosinophilic", "relevance"=>"HIGH"}, {"id"=>"M195803", "name"=>"Erythromycin stearate", "asFound"=>"Eosinophilic", "relevance"=>"HIGH"}, {"id"=>"M15640", "name"=>"Silver Nitrate", "asFound"=>"Surgery procedure", "relevance"=>"HIGH"}, {"id"=>"M4222", "name"=>"Anti-Bacterial Agents", "relevance"=>"LOW"}, {"id"=>"M4214", "name"=>"Anti-Infective Agents", "relevance"=>"LOW"}, {"id"=>"M8881", "name"=>"Gastrointestinal Agents", "relevance"=>"LOW"}, {"id"=>"M7951", "name"=>"Enzyme Inhibitors", "relevance"=>"LOW"}, {"id"=>"M4215", "name"=>"Anti-Infective Agents, Local", "relevance"=>"LOW"}], "browseBranches"=>[{"name"=>"Anti-Infective Agents", "abbrev"=>"Infe"}, {"name"=>"Gastrointestinal Agents", "abbrev"=>"Gast"}, {"name"=>"All Drugs and Chemicals", "abbrev"=>"All"}]}}, "protocolSection"=>{"designModule"=>{"phases"=>["PHASE3"], "studyType"=>"INTERVENTIONAL", "designInfo"=>{"allocation"=>"RANDOMIZED", "maskingInfo"=>{"masking"=>"DOUBLE"}, "primaryPurpose"=>"TREATMENT"}}, "statusModule"=>{"overallStatus"=>"COMPLETED", "startDateStruct"=>{"date"=>"1985-01"}, "expandedAccessInfo"=>{"hasExpandedAccess"=>false}, "statusVerifiedDate"=>"2009-09", "lastUpdateSubmitDate"=>"2009-09-16", "studyFirstSubmitDate"=>"1999-09-23", "studyFirstSubmitQcDate"=>"1999-09-23", "lastUpdatePostDateStruct"=>{"date"=>"2009-09-17", "type"=>"ESTIMATED"}, "studyFirstPostDateStruct"=>{"date"=>"1999-09-24", "type"=>"ESTIMATED"}}, "conditionsModule"=>{"keywords"=>["Neonatal Conjunctivitis"], "conditions"=>["Chlamydia Infections", "Ophthalmia Neonatorum"]}, "referencesModule"=>{"references"=>[{"pmid"=>"8356971", "type"=>"BACKGROUND", "citation"=>"Krohn MA, Hillier SL, Bell TA, Kronmal RA, Grayston JT. The bacterial etiology of conjunctivitis in early infancy. Eye Prophylaxis Study Group. Am J Epidemiol. 1993 Sep 1;138(5):326-32. doi: 10.1093/oxfordjournals.aje.a116862."}, {"pmid"=>"8233733", "type"=>"BACKGROUND", "citation"=>"Bell TA, Grayston JT, Krohn MA, Kronmal RA. Randomized trial of silver nitrate, erythromycin, and no eye prophylaxis for the prevention of conjunctivitis among newborns not at risk for gonococcal ophthalmitis. Eye Prophylaxis Study Group. Pediatrics. 1993 Dec;92(6):755-60."}]}, "descriptionModule"=>{"briefSummary"=>"To compare the effectiveness of silver nitrate drops, erythromycin ointment, or no medication in preventing neonatal conjunctivitis caused by Chlamydia trachomatis and other eye infections.\n\nTo compare side effects of the two prophylactic agents.", "detailedDescription"=>"Sexually transmitted diseases are a major cause of neonatal eye infections. All 50 States require some eye treatment at birth to prevent gonorrheal eye infections. Approximately 3 to 4 million Americans acquire a genital chlamydial infection each year, and more than 150,000 infants are born to mothers with chlamydial infections. These infants are at high risk of developing conjunctivitis and pneumonia.\n\nIn the State of Washington, one of three treatments is presently required by law to help prevent gonorrheal eye infection in newborn babies: 1 percent silver nitrate drops, erythromycin ointment, or tetracycline ointment. Although all three treatments appear to prevent eye infections from gonorrhea, silver nitrate and erythromycin may also partially prevent chlamydial conjunctivitis. However, silver nitrate may irritate and damage the eyes of newborns.\n\nIf it is not known whether the mother is infected, it may be better not to give the drugs routinely. It could not be clearly established from the medical literature whether the risk to infants from no treatment was higher or lower than the risk from receiving a prophylactic agent. Many parents at low risk for gonorrhea prefer that no prophylaxis be given to their newborns. Moreover, Great Britain, which used no eye prophylactic agents for newborns for the 25 years preceding the study, has rates of neonatal conjunctivitis similar to those in the United States. For these reasons, the Washington State Board of Health granted this study an exemption from the State law to allow the investigators to evaluate scientifically the risks and benefits of no treatment.\n\nThe study was a randomized, double-masked clinical trials planned to include 1,200 infants born over 3 years. The trial compared the efficacy of two treatment regimens (silver nitrate and erythromycin) in two treatment groups to the outcomes in a control group receiving no prophylaxis. (Erythromycin was chosen over tetracycline as the antibiotic in this study because it is more commonly used in the United States for ocular prophylaxis.)\n\nWomen were recruited from the University of Washington Medical Center-associated obstetric units. Among the 2,577 women eligible for possible participation, 758 enrolled. Of these participants, 89 were not randomized. Among the 669 randomized women, 39 were not available for personal observation. These 39 were equally distributed among the three prophylaxis groups. In the final participant group, the infants of 630 women were evaluable.\n\nThe infants were randomly assigned to one of these three groups in the delivery room. Infants without conjunctivitis were monitored for 2 months after delivery. Infants who developed conjunctivitis were monitored for 2 months after successful treatment of their infection. The study included extensive efforts to determine the etiology of the conjunctivitis and to find nasolacrimal duct obstruction."}, "eligibilityModule"=>{"sex"=>"ALL", "stdAges"=>["CHILD"], "maximumAge"=>"1 year", "eligibilityCriteria"=>"The study included male and female infants delivered at University Hospital in Seattle, Washington. Women were recruited after the 28th week of pregnancy and had to be English-speaking. In addition, they planned to stay at the hospital at least 48 hours following delivery and lived in the greater Seattle metropolitan area. Infants were eligible whether they were delivered vaginally or by cesarean section. Excluded from the study were siblings of infants enrolled in the study, women who were culture-positive for gonorrhea, infants receiving systemic antimicrobials for reasons other than conjunctivitis, women receiving antimicrobials at the time of delivery, and families unlikely to be available for followup after delivery."}, "identificationModule"=>{"nctId"=>"NCT00000120", "briefTitle"=>"Clinical Trial of Eye Prophylaxis in the Newborn", "organization"=>{"class"=>"NIH", "fullName"=>"National Eye Institute (NEI)"}, "orgStudyIdInfo"=>{"id"=>"NEI-19"}}, "armsInterventionsModule"=>{"interventions"=>[{"name"=>"Erythromycin Ointment", "type"=>"DRUG"}, {"name"=>"Silver Nitrate Drops", "type"=>"DRUG"}]}, "sponsorCollaboratorsModule"=>{"leadSponsor"=>{"name"=>"National Eye Institute (NEI)", "class"=>"NIH"}}}}
